CLNN
Price
$3.00
Change
-$0.17 (-5.36%)
Updated
Apr 25 closing price
Capitalization
25.89M
FBRX
Price
$6.71
Change
-$0.25 (-3.59%)
Updated
Apr 25 closing price
Capitalization
44.14M
Ad is loading...

CLNN vs FBRX

Header iconCLNN vs FBRX Comparison
Open Charts CLNN vs FBRXBanner chart's image
Clene
Price$3.00
Change-$0.17 (-5.36%)
Volume$94.24K
Capitalization25.89M
Forte Biosciences
Price$6.71
Change-$0.25 (-3.59%)
Volume$28.91K
Capitalization44.14M
CLNN vs FBRX Comparison Chart
Loading...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLNN vs. FBRX commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLNN is a Buy and FBRX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (CLNN: $3.00 vs. FBRX: $6.71)
Brand notoriety: CLNN and FBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLNN: 164% vs. FBRX: 79%
Market capitalization -- CLNN: $25.89M vs. FBRX: $44.14M
CLNN [@Biotechnology] is valued at $25.89M. FBRX’s [@Biotechnology] market capitalization is $44.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLNN’s FA Score shows that 0 FA rating(s) are green whileFBRX’s FA Score has 0 green FA rating(s).

  • CLNN’s FA Score: 0 green, 5 red.
  • FBRX’s FA Score: 0 green, 5 red.
According to our system of comparison, FBRX is a better buy in the long-term than CLNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLNN’s TA Score shows that 4 TA indicator(s) are bullish while FBRX’s TA Score has 5 bullish TA indicator(s).

  • CLNN’s TA Score: 4 bullish, 4 bearish.
  • FBRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, FBRX is a better buy in the short-term than CLNN.

Price Growth

CLNN (@Biotechnology) experienced а 0.00% price change this week, while FBRX (@Biotechnology) price change was -8.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

Reported Earning Dates

CLNN is expected to report earnings on Mar 24, 2025.

FBRX is expected to report earnings on Mar 28, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FBRX($44.1M) has a higher market cap than CLNN($25.9M). CLNN YTD gains are higher at: -43.503 vs. FBRX (-70.468). CLNN has higher annual earnings (EBITDA): -29.61M vs. FBRX (-35.6M). FBRX has more cash in the bank: 16.4M vs. CLNN (14.6M). CLNN has higher revenues than FBRX: CLNN (421K) vs FBRX (0).
CLNNFBRXCLNN / FBRX
Capitalization25.9M44.1M59%
EBITDA-29.61M-35.6M83%
Gain YTD-43.503-70.46862%
P/E RatioN/AN/A-
Revenue421K0-
Total Cash14.6M16.4M89%
Total Debt22.9MN/A-
FUNDAMENTALS RATINGS
CLNN vs FBRX: Fundamental Ratings
CLNN
FBRX
OUTLOOK RATING
1..100
907
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
9265
P/E GROWTH RATING
1..100
9644
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLNN's Valuation (50) in the null industry is in the same range as FBRX (50). This means that CLNN’s stock grew similarly to FBRX’s over the last 12 months.

CLNN's Profit vs Risk Rating (100) in the null industry is in the same range as FBRX (100). This means that CLNN’s stock grew similarly to FBRX’s over the last 12 months.

FBRX's SMR Rating (96) in the null industry is in the same range as CLNN (99). This means that FBRX’s stock grew similarly to CLNN’s over the last 12 months.

FBRX's Price Growth Rating (65) in the null industry is in the same range as CLNN (92). This means that FBRX’s stock grew similarly to CLNN’s over the last 12 months.

FBRX's P/E Growth Rating (44) in the null industry is somewhat better than the same rating for CLNN (96). This means that FBRX’s stock grew somewhat faster than CLNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLNNFBRX
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 8 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 20 days ago
79%
Bullish Trend 12 days ago
73%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VBTX23.300.17
+0.73%
Veritex Holdings
ROK248.38-0.16
-0.06%
Rockwell Automation
MMSI94.61-0.06
-0.06%
Merit Medical Systems
PULM6.71-0.06
-0.89%
Pulmatrix
AFCG5.29-0.07
-1.31%
Advanced Flower Capital Inc

FBRX and

Correlation & Price change

A.I.dvisor tells us that FBRX and QSI have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FBRX and QSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBRX
1D Price
Change %
FBRX100%
-3.64%
QSI - FBRX
33%
Poorly correlated
+0.82%
AXON - FBRX
31%
Poorly correlated
+2.22%
ARRY - FBRX
28%
Poorly correlated
+10.09%
CLNN - FBRX
27%
Poorly correlated
-5.36%
CDTX - FBRX
27%
Poorly correlated
+0.28%
More